National Science Library, Chinese Academy of Sciences
  登录 机构网站 ENGLISH
您当前的位置是:电子期刊浏览 --> 卷期浏览
The lancet oncology(11,542)
ISSN: 1470-2045
1    
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3... 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:16  Issue:4  Page:375-384  

Weber Jeffrey S Dr;   D'Angelo Sandra P MD;   Minor David MD;   Hodi F Stephen MD;   Gutzmer Ralf MD;   ...

来源数据库:[Web of Science, Scopus]         被引频次:1145

文摘信息 获取全文 问图书馆员

2    
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021... 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:17  Issue:11  Page:1497-1508  

Langer Corey J Dr Prof;   Gadgeel Shirish M Prof;   Borghaei Hossein DO;   Papadimitrakopoulou Vassiliki A Prof;   Patnaik Amita MD;   ...

来源数据库:[Web of Science, Scopus]         被引频次:503

文摘信息 获取全文 问图书馆员

3    
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phas... 期刊论文

The Lancet Oncology     ISSN:1470-2045  Volume:18  Issue:9  Page:1182-1191  

Overman Michael J;   McDermott Ray;   Leach Joseph L;   Lonardi Sara;   Lenz Heinz-Josef;   ...

来源数据库:[Web of Science, Scopus]         被引频次:315

文摘信息 获取全文 问图书馆员

4    
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:18  Issue:3  Page:312-322  

Sharma Padmanee Prof;   Retz Margitta Prof;   Siefker-Radtke Arlene MD;   Baron Ari MD;   Necchi Andrea MD;   ...

来源数据库:[Web of Science, Scopus]         被引频次:356

文摘信息 获取全文 问图书馆员

5    
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:16  Issue:8  Page:908-918  

Ribas Antoni Prof;   Puzanov Igor MD;   Dummer Reinhard Prof;   Schadendorf Dirk Prof;   Hamid Omid MD;   ...

来源数据库:[Web of Science, Scopus]         被引频次:688

文摘信息 获取全文 问图书馆员

6    
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicen... 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:17  Issue:7  Page:956-965  

Seiwert Tanguy Y Dr;   Burtness Barbara MD;   Mehra Ranee;   Weiss Jared MD;   Berger Raanan MD;   ...

来源数据库:[Web of Science, Scopus]         被引频次:477

文摘信息 获取全文 问图书馆员

7    
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a ... 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:16  Issue:3  Page:257-265  

Rizvi Naiyer A Dr;   Mazières Julien Prof;   Planchard David MD;   Stinchcombe Thomas E MD;   Dy Grace K MD;   ...

来源数据库:[Web of Science, Scopus]         被引频次:716

文摘信息 获取全文 问图书馆员

8    
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:17  Issue:10  Page:1374-1385  

Kaufman Howard L Prof;   Russell Jeffery MD;   Hamid Omid MD;   Bhatia Shailender MD;   Terheyden Patrick MD;   ...

来源数据库:[Web of Science, Scopus]         被引频次:369

文摘信息 获取全文 问图书馆员

9    
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-ne... 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:16  Issue:1  Page:25-35  

Finn Richard S MD;   Crown John P Prof;   Lang Istvan MD;   Boer Katalin MD;   Bondarenko Igor M Prof;   ...

来源数据库:[Web of Science, Scopus]         被引频次:766

文摘信息 获取全文 问图书馆员

10    
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two random... 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:16  Issue:2  Page:141-151  

Yang James Chih-Hsin Prof;   Wu Yi-Long Prof;   Schuler Martin Prof;   Sebastian Martin MD;   Popat Sanjay FRCP;   ...

来源数据库:[Web of Science, Scopus]         被引频次:690

文摘信息 获取全文 问图书馆员

11    
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a... 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:15  Issue:11  Page:1224-1235  

Wilke Hansjochen Prof;   Muro Kei MD;   Van Cutsem Eric Prof;   Oh Sang-Cheul Prof;   Bodoky György Prof;   ...

来源数据库:[Web of Science, Scopus]         被引频次:802

文摘信息 获取全文 问图书馆员

12    
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA... 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:16  Issue:2  Page:187-199  

Bradley Jeffrey D Prof;   Paulus Rebecca BS;   Komaki Ritsuko Prof;   Masters Gregory MD;   Blumenschein George Prof;   ...

来源数据库:[Web of Science, Scopus]         被引频次:688

文摘信息 获取全文 问图书馆员

13    
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previou... 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:17  Issue:4  Page:425-439  

Cristofanilli Massimo Prof;   Turner Nicholas C MD;   Bondarenko Igor Prof;   Ro Jungsil MD;   Im Seock-Ah MD;   ...

来源数据库:[Web of Science, Scopus]         被引频次:406

文摘信息 获取全文 问图书馆员

14    
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:17  Issue:7  Page:883-895  

Antonia Scott J Prof;   López-Martin José A MD;   Bendell Johanna MD;   Ott Patrick A MD;   Taylor Matthew MD;   ...

来源数据库:[Web of Science, Scopus]         被引频次:370

文摘信息 获取全文 问图书馆员

15    
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:16  Issue:6  Page:630-637  

Chang Joe Y Prof;   Senan Suresh Prof;   Paul Marinus A MD;   Mehran Reza J Prof;   Louie Alexander V MD;   ...

来源数据库:[Web of Science, Scopus]         被引频次:581

文摘信息 获取全文 问图书馆员

16    
Carcinogenicity of consumption of red and processed meat 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:16  Issue:16  Page:1599-1600  

Bouvard Véronique;   Loomis Dana;   Guyton Kathryn Z;   Grosse Yann;   Ghissassi Fatiha El;   ...

来源数据库:[Web of Science, Scopus]         被引频次:412

获取全文 问图书馆员

17    
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:16  Issue:9  Page:1090-1098  

Shapiro Joel Dr;   van Lanschot J Jan B Prof;   Hulshof Maarten C C M MD;   van Hagen Pieter MD;   van Berge Henegouwen Mark I MD;   ...

来源数据库:[Web of Science, Scopus]         被引频次:509

文摘信息 获取全文 问图书馆员

18    
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 ... 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:15  Issue:10  Page:1065-1075  

Heinemann Volker Prof;   von Weikersthal Ludwig Fischer MD;   Decker Thomas MD;   Kiani Alexander Prof;   Vehling-Kaiser Ursula MD;   ...

来源数据库:[Web of Science, Scopus]         被引频次:759

文摘信息 获取全文 问图书馆员

19    
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an ... 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:15  Issue:2  Page:213-222  

Wu Yi-Long Prof;   Zhou Caicun Prof;   Hu Cheng-Ping Prof;   Feng Jifeng Prof;   Lu Shun Prof;   ...

来源数据库:[Web of Science, Scopus]         被引频次:887

文摘信息 获取全文 问图书馆员

20    
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:18  Issue:1  Page:31-41  

Hellmann Matthew D Dr;   Rizvi Naiyer A Prof;   Goldman Jonathan W MD;   Gettinger Scott N MD;   Borghaei Hossein DO;   ...

来源数据库:[Web of Science, Scopus]         被引频次:313

文摘信息 获取全文 问图书馆员

< 上一页 1 2 3 4 5 下一页 >
作者信息:×